Cargando…

The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange

The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various studies. However, the structure–function assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhne, Felix, Bonnington, Lea, Malik, Sebastian, Thomann, Marco, Avenal, Cecile, Cymer, Florian, Wegele, Harald, Reusch, Dietmar, Mormann, Michael, Bulau, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963987/
https://www.ncbi.nlm.nih.gov/pubmed/31581521
http://dx.doi.org/10.3390/antib8040049
_version_ 1783488408977408000
author Kuhne, Felix
Bonnington, Lea
Malik, Sebastian
Thomann, Marco
Avenal, Cecile
Cymer, Florian
Wegele, Harald
Reusch, Dietmar
Mormann, Michael
Bulau, Patrick
author_facet Kuhne, Felix
Bonnington, Lea
Malik, Sebastian
Thomann, Marco
Avenal, Cecile
Cymer, Florian
Wegele, Harald
Reusch, Dietmar
Mormann, Michael
Bulau, Patrick
author_sort Kuhne, Felix
collection PubMed
description The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various studies. However, the structure–function assessment for protein drugs in biopharmaceutical research and development is often impeded by the relatively low-abundance (below 5%) of critical quality attributes or by overlapping effects of modifications, such as glycosylation, with chemical amino acid modifications; e.g., oxidation or deamidation. We present results demonstrating the applicability of the H/DX-MS technique to monitor conformational changes of specific Fc glycosylation variants produced by in vitro glyco-engineering technology. A trend towards less H/DX in Fc Cγ2 domain segments correlating with larger glycan structures could be confirmed. Furthermore, significant deuterium uptake differences and corresponding binding properties to Fc receptors (as monitored by SPR) between α-2,3- and α-2,6-sialylated Fc glycosylation variants were verified at sensitive levels.
format Online
Article
Text
id pubmed-6963987
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69639872020-01-27 The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange Kuhne, Felix Bonnington, Lea Malik, Sebastian Thomann, Marco Avenal, Cecile Cymer, Florian Wegele, Harald Reusch, Dietmar Mormann, Michael Bulau, Patrick Antibodies (Basel) Article The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various studies. However, the structure–function assessment for protein drugs in biopharmaceutical research and development is often impeded by the relatively low-abundance (below 5%) of critical quality attributes or by overlapping effects of modifications, such as glycosylation, with chemical amino acid modifications; e.g., oxidation or deamidation. We present results demonstrating the applicability of the H/DX-MS technique to monitor conformational changes of specific Fc glycosylation variants produced by in vitro glyco-engineering technology. A trend towards less H/DX in Fc Cγ2 domain segments correlating with larger glycan structures could be confirmed. Furthermore, significant deuterium uptake differences and corresponding binding properties to Fc receptors (as monitored by SPR) between α-2,3- and α-2,6-sialylated Fc glycosylation variants were verified at sensitive levels. MDPI 2019-10-01 /pmc/articles/PMC6963987/ /pubmed/31581521 http://dx.doi.org/10.3390/antib8040049 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kuhne, Felix
Bonnington, Lea
Malik, Sebastian
Thomann, Marco
Avenal, Cecile
Cymer, Florian
Wegele, Harald
Reusch, Dietmar
Mormann, Michael
Bulau, Patrick
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
title The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
title_full The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
title_fullStr The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
title_full_unstemmed The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
title_short The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
title_sort impact of immunoglobulin g1 fc sialylation on backbone amide h/d exchange
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963987/
https://www.ncbi.nlm.nih.gov/pubmed/31581521
http://dx.doi.org/10.3390/antib8040049
work_keys_str_mv AT kuhnefelix theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT bonningtonlea theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT maliksebastian theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT thomannmarco theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT avenalcecile theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT cymerflorian theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT wegeleharald theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT reuschdietmar theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT mormannmichael theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT bulaupatrick theimpactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT kuhnefelix impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT bonningtonlea impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT maliksebastian impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT thomannmarco impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT avenalcecile impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT cymerflorian impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT wegeleharald impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT reuschdietmar impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT mormannmichael impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange
AT bulaupatrick impactofimmunoglobuling1fcsialylationonbackboneamidehdexchange